Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
Israeli lawmakers pass bill reviving death penalty for terrorists- The Electric Toyota Hilux Is Finally here, But It's Not Cheap
- Vote in favor of your Favored kind of footwear
- Police investigate Lahav 433 officer accused of sexually harassing subordinate policewoman
- What do teens and tweens want for the holidays? E-bikes, gift cards and lip tints.
- Blue Origin launches New Glenn rocket on company's first NASA-scale science mission
- Dental Embed Developments: Upsetting Current Dentistry
- Exploring the Mind boggling Universe of Connections: Individual Bits of knowledge
- The top astronomical discoveries of 2025
